These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9769906)
41. Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors. Wu KC; Chiu HH; Wang JH; Lee NS; Lin HC; Hsieh CC; Tsai FJ; Peng CT; Tseng YC J Microbiol Immunol Infect; 2002 Mar; 35(1):53-6. PubMed ID: 11950121 [TBL] [Abstract][Full Text] [Related]
42. Antimicrobial susceptibility of community and hospital acquired bacteria. Danchaivijitr S; Dhiraputra C; Rongrungruang Y; Worajitr M; Jintanothaitavorn D J Med Assoc Thai; 2005 Dec; 88 Suppl 10():S14-25. PubMed ID: 16850635 [TBL] [Abstract][Full Text] [Related]
43. [Multiresistant bacteria in a Scandinavian perspective]. Kristinsson KG Nord Med; 1995; 110(2):42-4, 54. PubMed ID: 7854908 [TBL] [Abstract][Full Text] [Related]
44. [Surveillance of bacterial resistance in China (1998-1999)]. Li J; Weinstein AJ; Yang M; Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):8-16. PubMed ID: 11798843 [TBL] [Abstract][Full Text] [Related]
45. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic? Bonten MJ Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518 [TBL] [Abstract][Full Text] [Related]
46. [Surveillance of multiresistant bacteria: justification, role of the laboratory, indicators, and recent French data]. Marty L; Jarlier V Pathol Biol (Paris); 1998 Apr; 46(4):217-26. PubMed ID: 9769901 [TBL] [Abstract][Full Text] [Related]
47. Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors. Cars O Drugs; 1997; 54 Suppl 6():4-10. PubMed ID: 9474476 [TBL] [Abstract][Full Text] [Related]
48. [Epidemiologic study of infection by resistant gram-positive bacteria (G + R Study)]. Betriu C; Ali Sánchez B; Picazo JJ; Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):7-11. PubMed ID: 12550038 [TBL] [Abstract][Full Text] [Related]
49. Antibacterial resistance in the intensive care unit: mechanisms and management. Elliott TS; Lambert PA Br Med Bull; 1999; 55(1):259-76. PubMed ID: 10695090 [TBL] [Abstract][Full Text] [Related]
50. The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications. Acevedo J; Silva A; Prado V; Fernández J Hepatol Int; 2013 Mar; 7(1):72-9. PubMed ID: 26201623 [TBL] [Abstract][Full Text] [Related]
58. [Prevention multi-resistant bacterial infections in resuscitation (excluding modalities of optimization of antibiotic therapy). 16th Consensus Conference on resuscitation and emergency medicine. 1996 November 21 Thursday, Scientific Information Center of ARC, Villejuif]. Rev Pneumol Clin; 1997; 53(2):107-10. PubMed ID: 9205692 [No Abstract] [Full Text] [Related]
59. Emerging multiresistant organisms in the ICU: epidemiology, risk factors, surveillance, and prevention. Broadhead JM; Parra DS; Skelton PA Crit Care Nurs Q; 2001 Aug; 24(2):20-9. PubMed ID: 11858419 [TBL] [Abstract][Full Text] [Related]
60. [Role of multi-resistant bacteria in pediatrics]. Raymond J; Bergeret M; Aujard Y Arch Pediatr; 2002 May; 9 Suppl 2():140s-142s. PubMed ID: 12108247 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]